Miss Nancy Othman, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 2000 Tyler Avenue, Soth El Monte, CA 91733 Phone: 626-543-4462 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
The diagnosis of male fertility is usually performed through the observation of the sperm in the microscope. However, a normal quality semen does not guarantee an adequate fertility. In fact, there is a considerable proportion of cases of unexplained infertility and data suggest that abnormal sperm function may have a genetic or molecular origin.
A permanent ban on abortion funding is long overdue, which is why the U.S. bishops support the No Taxpayer Funding of Abortion Act (H.R. 3), said a representative of the United States Conference of Catholic Bishops in a February 8 testimony to the Subcommittee on the Constitution of the House Judiciary Committee.
An industry-first technology developed by Loughborough University has the potential to significantly cut nitrogen oxide (NOx) emissions in diesel engines.
Sudden unexpected death in epilepsy (SUDEP) is the most common condition-related cause of death in chronic epilepsy. Case-control studies using living people with epilepsy as controls have aimed at identifying factors that distinguish the epilepsy patient at risk of SUDEP, but there are disagreements between studies and a lack of precision in the risk estimates attributed, in part, to the small number of cases in each study.
› Verified 9 days ago